Prabhudas Lilladher's research report on HCL Technologies
HCLT reported strong revenue growth of 6% QoQ CC slightly below our estimates (Ple: 6.5%, Cons:6.4%) of which organic growth accounted to 1.5% QoQ CC higher than our estimates of 0.8% QoQ CC. Strong revenue growth was led by ERD segment (+5.4% QoQ). IBM products contributed ~US$105mn (~4.4%) in incremental revenues. EBIT margin increased by 286bps QoQ to 20% ahead of HCLT guided range of 18.5-19.5% due to improvement in core business, benefits from the consolidation of the higher-margin IP business. ER&D margins also increased sharply by 540bps QoQ to 21.4% on account of productivity improvements and recognition of deferred revenue.
Outlook
We fine tune our estimates & incorporate FY22E estimates & now value HCLT based on Sep-21 earnings of Rs.90 valuing at 14x multiple & arriving at a changed target price of Rs.1258(earlier: Rs. 1210). Stock is currently trading at 12.7x FY21E EPS and 11.8x FY22E EPS. HCLT remains our top pick in overall IT coverage universe.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!